Global Provider Signs Long-Term Agreement with Vertex Pharmaceuticals for CASGEVY™ KAISERAUGST, Switzerland, Jan. 23, 2024 /PRNewswire/ — Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today that it will perform analytical release testing…
Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy
You Might Also Like
Sign Up For Daily Newsletter
Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
admin
Leave a comment
Leave a comment
Stay Connected
- Advertisement -